| 2024-05 |
ctDNA predicts clinical T1a to pathological T3a upstaging after partial nephrectomy |
Cancer Science
|
| 2024-04 |
Clinical Validation of the Proenkephalin (PENK) Methylation Urine Test for Monitoring Recurrence of Non–muscle-invasive Bladder Cancer |
European Urology Open Science
|
| 2024-02 |
Role of Maximal Transurethral Resection Preceding Partial Cystectomy for Muscle-Invasive Bladder Cancer |
Annals of Surgical Oncology
|
| 2024-01 |
PD-1 inhibitor plus oncolytic vaccinia virus is a safe and effective treatment option for metastatic renal cell carcinoma |
Cancer Cell International
|
| 2023-11 |
Prediction of Stent Failure for Malignant Ureteral Obstruction in Non-Urological Cancer |
Yonsei Medical Journal
|
| 2023-07 |
Outcomes of single-port robotic ureteral reconstruction using the da Vinci SP® system |
Investigative and Clinical Urology
|
| 2023-03 |
Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up |
Journal of Urologic Oncology
|
| 2023-01 |
Phosphodiesterase-5 Inhibitor Use in Robot Assisted Radical Prostatectomy Patients Is Associated with Reduced Risk of Death: A Propensity Score Matched Analysis of 1,058 Patients |
The World Journal of Men's Health
|
| 2022-12 |
Noninvasive studies may have potential to replace cystoscopy in non-muscle invasive bladder cancer follow-up |
Scientific Reports
|
| 2022-11 |
Characteristics of BRCA2 Mutated Prostate Cancer at Presentation |
International Journal of Molecular Sciences
|
| 2022-10 |
Clinical Implications for da Vinci SP Partial Nephrectomy in High-Complexity Tumors: Propensity Score-Matching Analysis |
Journal of Endourology
|
| 2022-09 |
Nephron-Sparing Approaches in Upper Tract Urothelial Carcinoma: Current and Future Strategies |
Biomedicines
|
| 2022-02 |
Evaluation of the Surgical Margin Threshold for Avoiding Recurrence after Partial Nephrectomy in Patients with Renal Cell Carcinoma |
YONSEI MEDICAL JOURNAL
|